Effects of Ublituximab on Motor Functions in Multiple Sclerosis

NCT06629428 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Multiple Sclerosis (MS) - Relapsing-remitting

Interventions

DRUG: Ublituximab

Sponsor

Georgia State University

Collaborators

[object Object]